Expression of tissue inhibitor of metalloproteinase-4 in normal human corneal cells and experimental corneal neovascularization

Ophthalmic Research

Volumn 35, Issue 4, 2003, Pages 199-207

  Ma, David Hui Kang ^a,b   Zhang, Fen ^b   Shi, Wen ^c   Yao, Jeng Yuan ^a   Hsiao, Ching Hsi ^a,b   Wu, Hui Chuan ^a   Kim, Wan Soo ^b,d,e   Hao, Yan Xia ^b   Hwang, David G ^b   Chen, Jan Kan ^f   Tsai, Ray Jui Fang ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c EXELIXIS INC   (United States)

^d Maryknoll Hospital   (South Korea)

^e Pusan National University   (South Korea)

^f CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Corneal neovascularization; Inflammation; Tissue inhibitors of metalloproteinase 4

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; METALLOPROTEINASE; METALLOPROTEINASE 4; MITOGENIC AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CONTROLLED STUDY; CORNEA CELL; CORNEA NEOVASCULARIZATION; ENZYME INHIBITION; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUTURING METHOD; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; CORNEAL NEOVASCULARIZATION; CORNEAL STROMA; DISEASE MODELS, ANIMAL; ENDOTHELIUM, CORNEAL; ENZYME INHIBITORS; EPITHELIUM, CORNEAL; FEMALE; FIBROBLASTS; IMMUNOENZYME TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0038647283     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000071171     Document Type: Article

References (40)

1. Casey R, Li WW: Factors controlling ocular angiogenesis. Am J Ophthalmol 1997;124:521-529.
2. Cao Y: Endogenous angiogenesis inhibitors and their therapeutic implications. Int J Biochem Cell Biol 2001;33:357-369.
3. Senger DR: Molecular framework for angiogenesis: A complex web of interactions between extravasated plasma proteins and endothelial cell proteins induced by angiogenic cytokines [comment]. Am J Pathol 1996;149:1-7.
4. Hernandez-Quintela E, Azar DT, O'Reilly MS: The role of angiostatin in the cornea after wounding. Invest Ophthalmol Vis Sci 1999;40:S97.
5. Lin HC, Chang JH, Jain S, Gabison EE, Kure T, Kato T, Fukai N, Azar DT: Matrilysin cleavage of corneal collagen type XVIII NC1 domain and generation of a 28-kD fragment. Invest Ophthalmol Vis Sci 2001;42:2517-2524.
6. Hiscott P, Seitz B, Schlotzer-Schrehardt U, Naumann GO: Immunolocalization of thrombospondin 1 in human, bovine, and rabbit cornea. Cell Tissue Res 1997;289:307-310.
7. Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W, Bouck NP: Pigment epithelium-derived factor: A potent inhibitor of angiogenesis. Science 1999;285:245-248.
8. Peek R, van Gelderen BE, Bruinenberg M, Kijlstra A: Molecular cloning of a new angiopoietin-like factor from the human cornea. Invest Ophthalmol Vis Sci 1998;39:1782-1788.
9. Tervo T, Tervo K, van Setten GB, Virtanen I, Tarkksnen A: Plasminogen activator and its inhibitor in the experimental corneal wound. Exp Eye Res 1989;48:445-449.
10. Mirshahi M, Mirshahi S, Soria C, Soria J, Thornaidis A, Pouliguen Y, Faure JP: Production of proteases type plasminogen activators and their inhibitor in cornea. Biochem Biophy Res Commun 1989;160:1021-1025.
11. Williams DL, Risse B, Kim S, Saunders D, Orlin S, Baker MS, Jensen PJ, Lavker RM: Plasminogen activator inhibitor type 2 in human corneal epithelium. Invest Ophthalmol Vis Sci 1999;40:1669-1675.
12. Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP: Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions. Eur J Cell Biol 1997;74:111-122.
13. Johnson MD, Kim HR, Chesler L, Tsa-Wu G, Bouck N, Polverini PJ: Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J Cell Physiol 1994;160:194-202.
14. Murphy AN, Unsworth EJ, Stetler-Stevenson WG: Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J Cell Physiol 1993;157:351-358.
15. Schnaper HW, Grant DS, Stetler-Stevenson WG, Fridman R, D'Orazi G, Murphy AN, Bird RE, Hoythya M, Fuerst TR, French DL, et al: Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. J Cell Physiol 1993;156:235-246.
16. Anand-Apte B, Pepper MS, Voest E, Montesano R, Olsen B, Murphy G, Apte SS, Zetters BR: Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3. Invest Ophthalmol Vis Sci 1997;38:817-823.
17. Wang M, Liu YE, Greene J, Sheng S, Fuchs A, Rosen EM, Shi YE: Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4. Oncogene 1997;14:2767-2774.
18. Corcoran ML, Hewitt RE, Kleiner DE Jr, Stetler-Stevenson WG: MMP-2: Expression, activation and inhibition. Enzyme Protein 1996;49:7-19.
19. Yu AE, Murphy AN, Stetler-Stevenson WG: 72-kD gelatinase (gelatinase A): Structure, activation, regulation, and substrate specificity; in Parks WC, Mecham RP (eds): Matrix Metalloproteinases. San Diego, Academic Press, 1998, pp 85-113.
20. Liu YE, Wang M, Greene J, Su J, Ullrich S, Li H, Sheng S, Alexander P, Sang QA, Shi YE: Preparation and characterization of recombinant tissue inhibitor of metalloproteinase 4 (TIMP-4). J Biol Chem 1997;272:20479-20483.
21. Kenney MC, Chwa M, Alba A, Saghizadeh M, Huang ZS, Brown DT: Localization of TIMP-1, TIMP-2, TIMP-3, gelatinase A and gelatinase B in pathological human corneas. Curr Eye Res 1998;17:238-246.
22. Alexander JP, Samples JR, Van Buskirk EM, Acott TS: Expression of matrix metalloproteinases and inhibitor by human trabecular meshwork. Invest Ophthalmol Vis Sci 1991;32:172-180.
23. Alexander JP, Samples JR, Acott TS: Growth factor and cytokine modulation of trabecular meshwork matrix metalloproteinase and TIMP expression. Curr Eye Res 1998;17:276-285.
24. Steen B, Sejersen S, Berglin L, Seregard S, Kvanta A: Matrix metalloproteinases and metalloproteinase inhibitors in choroidal neovascular membranes. Invest Ophthalmol Vis Sci 1998;39:2194-2200.
25. Della NG, Campochiaro PA, Zack DJ: Localization of TIMP-3 mRNA expression to the retinal pigment epithelium. Invest Ophthalmol Vis Sci 1996;37:1921-1924.
26. Greene J, Wang M, Liu YE, Raymond LA, Rosen C, Shi YE: Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem 1996;271:30375-30380.
27. Li YY, Feldman A, Sun Y, McTiernan CF: Differential expression of tissue inhibitors of metalloproteinases in the failing human heart. Circulation 1998;98:1728-1734.
28. Wu I, Moses MA: Molecular cloning and expression analysis of the cDNA encoding rat tissue inhibitor of metalloproteinase-4. Matrix Biol 1998;16:339-342.
29. Ma DH, Chen JK, Kim WS, Hao YX, Wu HC, Tsai RJ, Hwang DG, Zhang F: Expression of matrix metalloproteinase-2, -9 and tissue inhibitor of metalloproteinase-1, -2 in inflammation-induced corneal neovascularization. Ophthalmic Res 2001;33:353-362.
30. Kvanta A, Sarman S, Fagerholm P, Sergard S, Steen B: Expression of matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in inflammation-associated corneal neovascularization. Exp Eye Res 2000;70:419-428.
31. Zhang H, Li C, Baciu PC: Expression of integrins and MMPs during alkaline-burn-induced corneal angiogenesis. Invest Ophthalmol Vis Sci 2002;43:955-962.
32. Tsai RJ, Ho YS, Chen JK: The effects of fibroblasts on the growth and differentiation of human bulbar conjunctival epithelial cells in an in vitro conjunctival equivalent. Invest Ophthalmol Vis Sci 1994;35:2865-2875.
33. Vranka JA, Johnson E, Zhu X, Shepardson A, Alexander JP, Brandley JM, Wirtz MK, Weleber RG, Klein ML, Acott TS: Discrete expression and distribution pattern of TIMP-3 in the human retina and choroid. Curr Eye Res 1997;16:102-110.
34. Dana MR, Streilein JW: Loss and restoration of immune privilege in eyes with corneal neovascularization. Invest Ophthalmol Vis Sci 1996;39:2245-2251.
35. Dana MR, Zhu SN, Yamada J: Topical modulation of interleukin-1 activity in corneal neovascularization. Cornea 1998;17:403-409.
36. Leco KJ, Khokha R, Pavloff N, Hawkes SP, Edwards DR: Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem 1994;269:9352-9360.
37. Ries C, Petrides PE: Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol Chem Hoppe Seyler 1995;376:345-355.
38. Moses MA: The regulation of neovascularization of matrix metalloproteinases and their inhibitors. Stem Cells 1997;15:180-189.
39. Mignatti P, Rifkin DB: Plasminogen activators and matrix metalloproteinases in angiogenesis. Enzyme Protein 1996;49:117-137.
40. Pintucci G, Bikfalvi A, Klein S, Rifkin DB: Angiogenesis and the fibrinolytic system. Semin Thromb Hemost 1996;22:517-524.